Novo Nordisk sues Hims over Wegovy patent infringement, considers seeking ‘hundreds of millions’ in damagesnews2026-02-09T12:04:55+00:00February 9th, 2026|Endpoints News|
Hims says it will stop selling GLP-1 pill, after legal pressure from USnews2026-02-07T20:24:40+00:00February 7th, 2026|Endpoints News|
US calls for DOJ investigation of Hims over GLP-1 drugsnews2026-02-06T23:08:43+00:00February 6th, 2026|Endpoints News|
Post-Hoc Live: Analyzing the Novo vs. Hims GLP-1 showdownnews2026-02-06T12:00:29+00:00February 6th, 2026|Endpoints News|
Novo’s threat to sue Hims over Wegovy pill faces legal hurdlenews2026-02-05T21:25:38+00:00February 5th, 2026|Endpoints News|
Telehealth provider Hims goes after Novo’s weight loss pill with compounded versionnews2026-02-05T14:58:43+00:00February 5th, 2026|Endpoints News|
Midi Health raises $100M as it plans expansion into urgent care, researchnews2026-02-04T14:00:35+00:00February 4th, 2026|Endpoints News|
Carbon Health files for bankruptcy, seeking to sell or restructurenews2026-02-02T21:22:13+00:00February 2nd, 2026|Endpoints News|
